LLY Related StreetInsider.com Reports
-
Stocks Crossing 50-Day SMA 05/13: (ZNGA) (FB) (LLY) Above; (T) (AFFY) (BTU) Below
-
Lilly (LLY) to Halt Enzastaurin Production Following Phase III; Sees Charge
-
Eli Lilly (LLY) CEO Lechleiter to Take Scheduled Medical Leave
-
Eli Lilly & Co. (LLY) Declares $0.49 Quarterly Dividend; 3.6% Yield
-
Analyst Encouraged by Eli Lilly (LLY) Cost Containment Efforts
-
Eli Lilly & Co. (LLY) Tops Q1 EPS by 9c; Reaffirms FY13 Outlook
-
Trading Radar for 04/24: Ford (F), Boeing (BA), Zynga (ZNGA), Sprint (S), SUPERVALU (SVU) Report
-
Lilly (LLY) Reports Dulaglutide Met Primary Endpoints in Additional Phase IIs
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
Boehringer, Lilly (LLY) Empagliflozin MAA Accepted by EMA
-
Boehringer, Lilly (LLY) Launch MARLINA Trial
-
Market Wrap: (Most) Banks Pass Fed Muster; JPMorgan in Senate Hot Seat; Kerkorian Likes MGM
-
FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)
-
Zoetis (ZTS) Success Could Trigger Animal Healthcare Spin-Off Bonanza
-
Kowa, Lilly (LLY) Report LIVALO Met Primary Endpoint in Reducing LDL-C
-
Qiagen NV (QGEN) Enters Deal with Eli Lilly (LLY)
-
Eli Lilly (LLY) to Cease Tabalumab Phase 3 RA Program
-
Pfizer's Zoetis (ZTS) May be Largest IPO Since Facebook (FB)
-
Eli Lilly & Co. (LLY) Tops Q4 EPS by 3c; Boosts FY13 EPS Outlook
-
Trading Radar for 01/29: Ford (F), AK Steel (AKS), Corning (GLW), Pfizer (PFE), Harley-Davidson (HOG) Report
-
Notable Analyst Rating Changes 01/17: (CBS) (MDT) (A) Upgraded; (CSCO) (LEAP) (VVUS) Downgraded
-
CLSA Starts Eli Lilly (LLY) at Sell
-
Eli Lilly (LLY) Receives EC Approval of Amyvid for PET Imaging
-
Agilent's (A) Dako Enters Diagnostic Test Development Partnership with Lilly (LLY)
-
Boehringer, Lilly (LLY) Complete Four Phase 3s for Empagliflozin; Safety Profile Akin to Phase 2
-
Eli Lilly (LLY) Resumes Sole LY2605541 Development
-
Eli Lilly (LLY) Reaffirms FY12 Outlook, Issues Strong FY13 Expectations
-
Stocks Crossing 50-Day SMA 12/20: (WFT) (LLY) (DHI) Above; (SD) (VVUS) (DECK) Below
-
Lilly (LLY) Reaches Agreement with SEC Over FCPA; Will Pay $29.4M in Settlement
-
Stocks Crossing 50-Day SMA 12/18: (GM) (FITB) (GE) Above; (MO) (LO) (URRE) Below
-
Eli Lilly & Co. (lly) Declares $0.49 Quarterly Dividend; 4.1% Yield
-
Eli Lilly (LLY) Approves $1.5B Buyback Plan
-
Stocks Crossing 50-Day SMA 12/13: (P) (ZAGG) (RSH) Above; ((MET) (HES) (LLY) Below
-
Eli Lilly (LLY) to Discontinue One Tabalumab Phase 3 Study; Sees Q4 Charge
-
Lilly (LLY) Does Not Plan to Submit BLA for Solanezumab to FDA Following EXPEDITION Analysis
-
Anacor (ANAC) Achieves 2nd Candidate in Lilly (LLY) Collaboration
-
Citi Starts Eli Lilly (LLY) at Buy
-
Par Pharma (PRX) Begins U.S. Shipments of Generic Symbyax (LLY)
-
Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis
-
Boehringer, Lilly (LLY) Completes Enrollment in CAROLINA
-
Lilly (LLY) to Expand Insulin Ops in Indianapolis; Will Invest $140M
-
Lilly (LLY) Cialis Approved as BPH Treatment in Europe
-
Eli Lilly & Co. (LLY) Misses Q3 EPS by 3c; Reaffirms Outlok
-
Trading Radar for 10/24: AT&T (T), Wynn Resorts (WYNN), Fusion-io (FIO), Delta (DAL), Zynga (ZNGA), Cliffs Natural (CLF) Report
-
Eli Lilly (LLY) Reports Phase III AWARD Met All Primary Endpoints
-
Lilly's (LLY) Amyvid Receives Positive CHMP Opinion in the EU
-
Eli Lilly (LLY) Announces Expanded Indication for ALIMTA in Certain Lung Cancers
-
Eli Lilly & Co. (LLY) Declares $0.49 Quarterly Dividend; 3.7% Yield
-
Lilly's (LLY) Alimta ANDA Receives FDA Paragraph IV Certification
-
Notable ETF Movers of the Day 10/15: (ITB) (XLV) Higher; (GDX) Lower
Back to LLY Stock Lookup
